{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/73fe3ede-5c5c-4850-96a8-30db8dbae8bf/95d0b367-63b9-48bf-b73e-b45cdcc329a6?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Covid-19 vaccine makers seek protections, US homebuilder stocks rise, Ant IPO","description":"<p>European vaccine makers want EU exemptions that would protect them if there are problems with new Covid-19 vaccines, and low interest rates have helped US homebuilder stocks surge to record highs. Plus, the FT’s James Fontanella-Khan explains why Ant Group chose to list its potentially record setting IPO outside the US.&nbsp;</p><p><br></p><p><strong>Covid-19 vaccine makers lobby EU for legal protection</strong></p><p><a href=\"https://www.ft.com/content/12f7da5b-92c8-4050-bcea-e726b75eef4d?\" rel=\"noopener noreferrer\" target=\"_blank\"><strong>https://www.ft.com/content/12f7da5b-92c8-4050-bcea-e726b75eef4d?</strong></a></p><p><br></p><p><strong>Low rates help propel US homebuilder stocks to record highs</strong></p><p><a href=\"https://www.ft.com/content/9b54ab06-2d57-44a1-85c2-47c114589c22\" rel=\"noopener noreferrer\" target=\"_blank\"><strong>https://www.ft.com/content/9b54ab06-2d57-44a1-85c2-47c114589c22</strong></a></p><p><br></p><p><strong>Ant Group reveals $2.6bn profit as it files for blockbuster IPO</strong></p><p><a href=\"https://www.ft.com/content/b5f6fed2-2dcf-48dc-9097-a49bff5532dc\" rel=\"noopener noreferrer\" target=\"_blank\">https://www.ft.com/content/b5f6fed2-2dcf-48dc-9097-a49bff5532dc</a></p><p><br></p>","author_name":"Financial Times"}